Tyenne Unione Europea - italiano - EMA (European Medicines Agency)

tyenne

fresenius kabi deutschland gmbh - tocilizumab - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - immunosoppressori - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.

ANTISCABBIA CM CR 50G Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

antiscabbia cm cr 50g

candioli ist.profil.e farm.spa - benzile benzoato/permetrina/benzocaina - crema - "crema" tubo 50 g

CEFONICID COP IM 1FL 1G F 2,5M Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

cefonicid cop im 1fl 1g f 2,5m

copernico farmaceutici srl - cefonicid bisodico - preparazione iniettabile - "1000 mg/2,5 ml polvere e solvente per soluzione iniettabile per uso intramuscolare"1 flaconcino polvere + 1 fiala solvente 2,5

NOKID IM 1F 1G F 2,5ML Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

nokid im 1f 1g f 2,5ml

aurobindo pharma italia srl - cefonicid sodico - preparazione iniettabile - "1 g/2,5 ml polvere e solvente per soluzione iniettabile per uso intramuscolare"1 flacone polvere + 1 fiala solvente 2,5 ml

CEFONICID BIG IM FL 1G F 2,5ML Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

cefonicid big im fl 1g f 2,5ml

benedetti & co.spa - cefonicid sodico - preparazione iniettabile - "1 g/2,5 ml polvere e solvente per soluzione iniettabile per uso intramuscolare"1 flaconcino polvere + 1 fiala solvente 2,5 ml

CEFONICID DOROM IM F 1G F2,5ML Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

cefonicid dorom im f 1g f2,5ml

teva italia srl - cefonicid bisodico - preparazione iniettabile - " 1 g polvere e solvente per soluzione iniettabile per uso intramuscolare" 1 flaconcino + 1 fiala 2,5 ml

DAYCEF IM 1F 1G F 2,5ML Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

daycef im 1f 1g f 2,5ml

sarda pharmaceutica srl - cefonicid sodico - preparazione iniettabile - "1 g / 2,5 ml polvere e solvente per soluzione iniettabile per uso intramuscolare", 1 flaconcino polvere + 1 fiala solvente da 2

GABBRORAL 12CPR 250MG Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

gabbroral 12cpr 250mg

pfizer italia srl - paromomicina solfato - compresse - "250 mg compresse" 12 compresse

MELOXICAM HEX 30CPR 15MG Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

meloxicam hex 30cpr 15mg

sandoz spa - meloxicam - compresse - "15 mg compresse" 30 compresse in blister pvc/pvdc/al

NORAPRIL 28CPR 10MG Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

norapril 28cpr 10mg

benedetti & co.spa - ramipril - compresse - "10 mg compresse" 28 compresse in blister pvdc/pvc/al